Print Page   |   Contact Us   |   Your Cart   |   Sign In   |   Join
Journal CPE Programs
Share |


Journal CPE Programs

In order to process your CE credits, you must provide us with your correct NABP e-Profile ID number and your birth month and day (MMDD format). The NABP e-Profile ID number is a six to 10 digit number, and it is NOT your license number or NPI number.  If you need to verify the number or have not yet registered for one, please visit as soon as possible.

FDA Safety Warnings and Prescribing Updates: Fluoroquinolones, SGLT2 Inhibitors, and Metformin (expires 3-15-20)

2016 AACE/ACE Guidelines on Type 2 Diabetes Management and New Glycemic Control Agents
(expires 2-15-20)

New Drugs: Briviact, Cinqair, Nuplazid, Taltz
(expires 1-15-20)

Asthma: Approaches to Treatment and New Therapies
(expires 12-15-19)

Long-Acting Reversible Contraceptives
(expires 11-15-19)

Hepatitis C: Disease Review and New Era of Treatment
(expires 10-15-19)

Treatment of Pulmonary Disease in Cystic Fibrosis
(expires 9-15-19)

Prebiotics, Probiotics, and Synbiotics: Their Therapeutic Role
(expires 8-15-19)

A New Generation of Medical Errors with the Rise of Health Information Technology
 (expires 7-15-19)

New Drugs: Corlanor, Entresto, Vraylar, Rexulti
(expires 6-15-19)

Naloxone: Overview and Resources for Pharmacists (expires 5-15-19)

New Prescription Labeling Requirements for the Use of Medications in Pregnancy and Lactation
(expires 4-15-19)

Pneumococcal Disease: Treatment and Prevention
(expires 3-15-19)

Update on Cholesterol Treatment and Two New Drugs: Praluent and Repatha
(expires 2-15-19)

Management of Diarrhea-predominant Irritable Bowel Syndrome with Focus on Viberzi and Xifaxan (expires 1-15-19)

An Update on Smoking Cessation: Treatments and Electronic Cigarettes
(expires 12-15-18)

New Drugs: Cosentyx, Ibrance, Lenvima, and Unituxin (expires 11-15-18)

New Drugs: Beleodaq, Belsomra, Jardiance, and Zydelig (expires 5-15-18)


Mental Illness Counseling: Communication Strategies and Resources for Pharmacists (expires 4-15-18)

New Drugs: Dalvance, Entyvio, Jublia, and Zontivity (expires 3-15-2018)

Heartfailure: Updated Treatment Guidelines (expires 2-15-2018)

New Drugs: Cyramza, Sylvant, Tanzeum, and Zykadia (expires 1-15-2018)


Parkinson's Disease: Non-Pharmacological Interventions (expires 11-15-17)

Parkinson's Disease: Improving Symptom Control with Pharmacotherapy
(expires 10-15-17)

New Drugs: Impavido, Myalept, Neuraceq, and Otezla
(expires 9-15-17)

New Drugs: Farxiga, Hetlioz, Northera, and Vimizim (expires 7-15-17)

New Drugs: Aptiom, Imbruvica, Luzu, and Sovaldi (expires 6-15-17)

Atypical Antipsychotics: Overview, Metabolic Abnormalities, and Newer Agents (expires 5-15-17)

more Calendar


5/5/2017 » 5/6/2017
NCPA’s ‘Re-Engineering Your Pharmacy’ Boot Camp

WSPA Health System Pharmacy Leadership Roundtable

Online Surveys
1402 - ICU Medical Inc Campaign
Association Management Software Powered by YourMembership  ::  Legal